Wealth Enhancement Trust Services’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.48K Sell
111
-292
-72% -$17.2K ﹤0.01% 621
2026
Q2
$22.6K Buy
+403
New +$21K ﹤0.01% 605
2026
Q1
– Sell
-109
Closed -$4.21K – 815
2025
Q4
$4.21K Buy
+109
New +$4.16K ﹤0.01% 610

Other funds holding RPRX

Wealth Enhancement Trust Services's RPRX Position: Q3 2026 in Review

Wealth Enhancement Trust Services reduced its Royalty Pharma (RPRX) stake by 72% in Q3 2026, selling an estimated $17.2K and leaving 111 shares worth $6.48K. The position accounts for ﹤0.01% of the portfolio, ranked #621.

Wealth Enhancement Trust Services first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $22.6K in Q2 2026. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Wealth Enhancement Trust Services held 111 shares of Royalty Pharma worth $6.48K as of Q3 2026.
  • Wealth Enhancement Trust Services sold 292 Royalty Pharma shares in Q3 2026, an estimated $17.2K.
  • Royalty Pharma made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q3 2026, its #621 holding.
  • Wealth Enhancement Trust Services first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • Wealth Enhancement Trust Services's Royalty Pharma position peaked at $22.6K in Q2 2026.
  • 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.